Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 2/20 | 0.33 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.31 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.31 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethane SCHEMBL27259007 | 0.98 | FOLH1 (0.32) | FOLH1NAALAD2GABRR1CYP1A2ACE2 | |
| SCHEMBL27932300 | 0.85 | CHRM1 (0.42) | GABRR1CYP1A2ACE2CHRM1AKR1A1 | |
| SCHEMBL27536324 | 0.82 | CA2 (0.45) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL27948181 | 0.82 | ACE2 (0.46) | GABRR1CYP1A2ACE2CHRM1AKR1A1 | |
| SCHEMBL27932307 | 0.81 | SLC1A3 (0.36) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL27276142 | 0.81 | TSHR (0.35) | TSHR | |
| SCHEMBL27550458 | 0.81 | GPR84 (0.34) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| SCHEMBL28161640 | 0.81 | CHRM1 (0.31) | CHRM1AKR1A1CHRM3HTR2AHTR2C | |
| Lactic Acid SCHEMBL547542 | 0.79 | TP53 (0.50) | TSHR | |
| Cadaverine Tartrate SCHEMBL30203492 | 0.79 | TSHR (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105713281-B | Universal white master batch and preparation method thereof | 上海宏盎实业发展有限公司 | 2017-12-12 | — | — | CN | claimed |
| CN-105713281-A | Universal white master batch and preparation method thereof | 上海宏盎实业发展有限公司 | 2016-06-29 | — | — | CN | claimed |
| CN-110199005-A | The processing of sulfide dirt | 沙特阿拉伯石油公司 | 2019-09-03 | — | — | CN | disclosed |
| CN-109072056-A | Ion-containing polysaccharide-coated nanoparticle compositions | 沙特阿拉伯石油公司 | 2018-12-21 | — | — | CN | disclosed |
| CN-108026438-A | Stabilized nanoparticle compositions comprising ions | 沙特阿拉伯石油公司 | 2018-05-11 | — | — | CN | disclosed |
| CN-105713281-B | Universal white master batch and preparation method thereof | 上海宏盎实业发展有限公司 | 2017-12-12 | — | — | CN | disclosed |
| CN-105733158-B | Novel plastic filler parent granule | 上海宏盎实业发展有限公司 | 2017-10-10 | — | — | CN | disclosed |
| US-20170239366-A1 | ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES | GENENTECH, INC. (US) | 2017-08-24 | — | — | US | disclosed |
| CN-106661440-A | Composition including a curable resin and organophilically-modified clay for subterranean oil well applications | 哈利伯顿能源服务公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106311150-A | Preparation method of adsorbent for purification of trimethylolpropane trioleate | 王金桢 | 2017-01-11 | — | — | CN | disclosed |
| CN-105713281-A | Universal white master batch and preparation method thereof | 上海宏盎实业发展有限公司 | 2016-06-29 | — | — | CN | disclosed |
| CN-103477492-A | Non-aqueous electrolyte solution and electricity-storage device using same | UBE INDUSTRIES | 2013-12-25 | — | — | CN | disclosed |
| CN-1025740-C | Fluorine-containing copolymer composition | MITSUI PETROCHEMICAL IND (JP) | 1994-08-24 | — | — | CN | disclosed |
| CN-1053249-A | The fluorinated copolymer composition | MITSUI PETROCHEMICAL IND (JP) | 1991-07-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170239366-A1 | ANTI-B7-H4 ANTIBODIES AND IMMUNOCONJUGATES | CD44, NECTIN4, H1-4 | FOLH1 497/4885NAALAD2 2194/4885GABRR1 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.